Curative Health Services to Hold Second Quarter Conference Call.Business Editors HAUPPAUGE, N.Y.--(BUSINESS WIRE)--July 25, 2001 Curative curative /cur·a·tive/ (kur´ah-tiv) tending to overcome disease and promote recovery. cu·ra·tive adj. 1. Serving or tending to cure. 2. Health Services health services Managed care The benefits covered under a health contract , Inc. (Nasdaq: CURE) will hold a conference call to discuss the Company's second quarter 2001 results on Tuesday, July 31, at 10:00 a.m. Eastern Standard Time. The second quarter results will be announced on July 31, 2001 prior to the market opening. To participate in the conference call, dial 1-800-479-1628 approximately 5 to 10 minutes prior to the scheduled start time. If you are unable to participate, a digital replay of the call will be available from Tuesday, July 31 at 1:00 p.m. EST P.M. also p.m. or p.m. abbr. post meridiem Usage Note: By definition, 12 a.m. until midnight on Wednesday, August 8, by dialing 1-888-203-1122 and using confirmation code # 432460. The live broadcast of Curative Health Services quarterly conference call will be available online by going to www.curative.com and clicking on the link to Investor Relations Investor relations The process by which the corporation communicates with its investors. , and on vcall.com at http://www.vcall.com/NASApp/VCall/EventPage?ID=76588. An online replay will be available shortly after the call at those sites. About Curative Health Services Curative Health Services is a leading disease management company in chronic wound care. Curative provides a broad continuum of services to healthcare providers through a nationwide network. This national network of over 120 hospital-based Wound Care Centers in 33 states, has offered comprehensive treatment to over 300,000 patients, achieving more than a 90% patient satisfaction rate. About eBioCare eBioCare, a subsidiary of Curative Health Services, provides services to patients and physicians that facilitate the healthcare management process. These include services such as direct-to-patient overnight distribution of biopharmaceuticals, medication management, and a comprehensive resource of chronic condition medical information. This press release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Factors that might cause such differences include, but are not limited to, the termination or non-renewal of a material number of contracts, an inability to obtain new contracts, changes in the government regulations relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc the Company's wound care operations or the operations of eBioCare, changes in the regulations governing gov·ern v. gov·erned, gov·ern·ing, gov·erns v.tr. 1. To make and administer the public policy and affairs of; exercise sovereign authority in. 2. third party reimbursements for Curative services, manufacturing shortages of products sold by eBioCare, and the other risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. Readers of this press release are referred to the Company's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended December 31, 2000 for further discussion of these and other factors that could affect future results. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion